Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $88000.0.

  • Verrica Pharmaceuticals' Amortizatization of Intangibles fell 5294.12% to $88000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $390000.0, marking a year-over-year decrease of 2870.2%. This contributed to the annual value of $619000.0 for FY2024, which is 11643.36% up from last year.
  • Latest data reveals that Verrica Pharmaceuticals reported Amortizatization of Intangibles of $88000.0 as of Q3 2025, which was down 5294.12% from $81000.0 recorded in Q2 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Amortizatization of Intangibles peaked at $187000.0 during Q3 2024, and registered a low of $56000.0 during Q1 2021.
  • Over the past 5 years, Verrica Pharmaceuticals' median Amortizatization of Intangibles value was $71000.0 (recorded in 2023), while the average stood at $86789.5.
  • As far as peak fluctuations go, Verrica Pharmaceuticals' Amortizatization of Intangibles surged by 14285.71% in 2024, and later tumbled by 5294.12% in 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at $58000.0 in 2021, then increased by 20.69% to $70000.0 in 2022, then fell by 5.71% to $66000.0 in 2023, then soared by 107.58% to $137000.0 in 2024, then tumbled by 35.77% to $88000.0 in 2025.
  • Its Amortizatization of Intangibles was $88000.0 in Q3 2025, compared to $81000.0 in Q2 2025 and $84000.0 in Q1 2025.